DB-3Q for the Treatment of Medically Refractory Crohn's Disease

Clinical trial NCT07625293 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07625293
Sponsor: Direct Biologics, LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn Disease (CD)

Start date: 2026-06-01
Primary completion: 2027-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.